Chenomx is a leading developer of solutions to analyze Nuclear Magnetic Resonance (NMR) data. Chenomx's patented technology platform combines state-of-the-art spectroscopic technology for the identification of metabolic markers with advanced algorithms to provide quantitative analysis of biological samples. Learn more about Chenomx's technology and applications by reviewing our publications and application areas.

Chenomx offers access to its technology platform via both software and services:

News

June 24, 2008

Announcing Chenomx NMR Suite 5.1. Chenomx is pleased to announce the immediate availability of Chenomx NMR Suite 5.1. Learn more here.

December 12, 2007

Announcing Chenomx NMR Suite 5.0. Chenomx is pleased to announce the immediate availability of Chenomx NMR Suite 5.0. Learn more here.

June 20, 2007

Chenomx, Inc. Announces Availability of Expanded Compound Libraries, New 400 MHz Compound Library. Chenomx, Inc. is pleased to announce the release of Chenomx NMR Suite 4.62, featuring expanded compound libraries for 500 MHz, 600 MHz, 700 MHz, and 800 MHz spectrometers and a new 400 MHz compound library. Learn more here.

June 11, 2007

Chenomx and GeneGo Offer Metabolomics Data Integration. Chenomx, Inc., a leading provider of software and compound libraries for NMR-based metabolomics, and GeneGo, Inc., a worldwide leader in data analysis solutions for systems biology and pathway analysis, are pleased to announce a partnership to provide metabolomics data integration between their software products. (Full Press Release)

News Archive

Upcoming Events

June 17-20, 2008

Bio 2008, San Diego, CA. Come see Chenomx at booth EC-21 at Bio 2008.

April 28-29, 2008

Metabomeeting 2008, Lyon, France. Chenomx is a proud sponsor of Metabomeeting 2008.

September 20-24, 2008

Metabolomics Society 2008, Boston, MA. Chenomx is a proud sponsor of the 4th annual conference of the Metabolomics Society.

March 16-20, 2008

Society of Toxicology, Seattle, WA. Chenomx is a proud sponsor of the SoT conference.